Media releases
November 30, 2007 17:15 CET
Novartis completes its fifth share repurchase program
Basel, November 30, 2007 - Novartis has completed its fifth share repurchase program initiated on July 24, 2007, and during which 63,173,000 Novartis shares were purchased for a total of CHF 4 billion. The average purchase price per share was CHF 63.32.
Novartis intends to propose to shareholders at the next General Meeting in February 2008 to cancel all shares repurchased in the fifth program as well as the remaining 22,175,000 shares from the fourth program. The fourth share repurchase program was completed in July 2007. As a result, it is intended to cancel a total of 85,348,000 shares, which corresponds to 3.13% of the registered Novartis share capital.
# # #
Novartis Media Relations
|
John Gilardi
Novartis Global Media Relations
+41 61 324 3018 (direct)
+41 79 596 1408 (mobile)
|
|
e-mail: media.relations@novartis.com
Novartis Investor Relations
|
International |
North America |
|
Ruth Metzler-Arnold
Katharina Ambuehl
Pierre-Michel Bringer
Jason Hannon
Thomas Hungerbuehler
Richard Jarvis
Isabella Zinck
Central phone no: +41 61 324 7944
e-mail: investor.relations@novartis.com |
Jill Pozarek +1 212 830 2445
Edwin Valeriano +1 212 830 2456
e-mail: investor.relations@novartis.com |
Download:
Media release
The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.
Event calendar
Find out about past and upcoming events (e.g. sales results, pipeline updates and shareholder meetings) and download presentations.